Most recently, it has been reported that anti-TNF treatment for COVID-19 patients with rheumatoid arthritis diseases showed preventive effects against the high levels of cytokines involved in the immune response of infection, and the therapeutic application of anti-TNFs can lessen the incidence of severe inflammation of COVID-19 [46]. The gene discussed is TNF; the disease is infection.